Canary Capital has established a trust in Delaware for a potential exchange-traded fund (ETF) centered around the Injective blockchain's native token. The trust, named 'Canary Staked INJ ETF,' was created as the initial step towards offering a fund related to staked Injective. While filing for a trust in Delaware is typically the first move before seeking approval from the Securities and Exchange Commission to launch an ETF, it does not guarantee the actualization of the fund. Canary Capital previously filed for an ETF to hold TRX tokens from the Tron blockchain and stake a portion for yield generation. The Injective token has experienced a 3.7% increase in value following the establishment of the Delaware trust, with positive weekly growth. Despite regulatory concerns, analysts remain hopeful that legal obstacles for crypto ETFs can be resolved. Read more AI-generated news on: https://app.chaingpt.org/news

#ETF